Bader, Viola
Strasser, Bernhard
Hingerl, Lukas
Kovarik, Johannes J.
Frese, Sabina
Pfleger, Lorenz
Duguid, Anna
Osburg, Aaron
Krššák, Martin
Scherer, Thomas
Bogner, Wolfgang
Niess, Fabian https://orcid.org/0000-0003-1235-7595
Funding for this research was provided by:
European Research Council (101088351)
Austrian Science Fund (KLI 1106)
Austrian Science Fund (WEAVE I 6037)
National Institut of Health (R01EB031787)
Medical University of Vienna
Article History
Received: 29 September 2025
Revised: 15 December 2025
Accepted: 29 December 2025
First Online: 16 January 2026
Declarations
:
: J.J. Kovarik reports consulting activities for Atossa Therapeutics. The other authors declare no conflicts of interest.